Not finding it? Sign in to also search OpenAlex live.
-
Evaluation and refinement of thresholds for early migration of total knee replacements as an estimator of late aseptic loosening: an updated systematic review of RSA and survival studies
Raymond Puijk, Jiwanjot Singh, Rowan H Puijk, Elise K. Laende, José W M Plevier, Peter A. Nolte, +1 more
21citations -
Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study
Dirk Jan A. R. Moes, David J. van Westerloo, Sandra M. Arend, Jesse Joachim Swen, Annick de Vries, Henk‐Jan Guchelaar, +4 more
16citations -
Computer Adaptive vs. Non-adaptive Medical Progress Testing: Feasibility, Test Performance, and Student Experiences2024 Perspectives on Medical Education article Medicine Innovations in Medical Education Open access
Elise V. van Wijk, Jeroen Donkers, Peter C. J. de Laat, Ariadne A. Meiboom, Bram Jacobs, Jan Hindrik Ravesloot, +4 more
8citations -
REducing Delay through edUcation on eXacerbations (REDUX) in patients with COPD: a pilot study2020 Clinical eHealth article Medicine Chronic Obstructive Pulmonary Disease (COPD) Research Open access
Cynthia Hallensleben, Eline M. Meijer, Jaco Biewenga, Regien M.M. Kievits-Smeets, Marjan Veltman, Xiaoyue Song, +2 more
6citations -
Fixed dosing of tocilizumab in ICU admitted COVID-19 patients is a superior choice compared to bodyweight based dosing; an observational population pharmacokinetic and pharmacodynamic study
Dirk Jan A. R. Moes, David J. van Westerloo, Sandra M. Arend, Jesse Joachim Swen, Annick de Vries, Henk‐Jan Guchelaar, +4 more
3citations -
778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma2023 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access cited by 2 patents
Daniel J. Olson, James Larkin, Young Ki Hong, Sajeve Samuel Thomas, Juan Martín-Liberal, Andrew J.S. Furness, +13 more
3citations -
Abstract CT286: TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanoma
Sajeve Samuel Thomas, Young Ki Hong, Yazan Samhouri, James Larkin, Gino Kim In, Victoria G. Atkinson, +21 more
2citations -
Optimizing lipid-lowering therapy for acute coronary syndrome using a decision support system: insights from a cluster randomized trial2025 European Heart Journal - Digital Health article Medicine Lipoproteins and Cardiovascular Health Open access
Christophe A. T. Stevens, Jessica Louise Smith, Julia Brandts, Fotios Barkas, Maria Moreno Morales, Leila Janani, +59 more
2citations -
Analysis of pre-symptomatic Drosophila models for ALS and SMA reveals convergent impact on functional protein complexes linked to neuro-muscular degeneration2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Amyotrophic Lateral Sclerosis Research Open access
Marina L. García‐Vaquero, Barbara Flix, Marcelo Henrique Neves Pereira, Lucile Palin, Tânia Monteiro Marques, Francisco Rodrigues Pinto, +4 more
0citations -
#1920 Effects of sparsentan after maximized angiotensin receptor blocker (ARB) treatment in patients with IgA nephropathy (IgAN) in the PROTECT trial2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jürgen Floege, Dana V. Rizk, Priscila Preciado, Brad H. Rovin, Rob Geletka, Alex Mercer, +3 more
0citations